Positron emission tomography-computed tomography (PET-CT) is a medical analytical technique used to examine the metabolic activity of tissues. This technique makes the use of PET scanner and an X-ray CT scanner. The PET scanners are used to measure body functions, such as blood flow, oxygen usage, and glucose metabolism, whereas CT imaging uses X-ray equipment to produce pictures of organs to observe the functioning of tissues and organs. The combined use of PET-CT scans provides the images of precise location of abnormal metabolic activity in the body. The global PET-CT scanner device market accounted for $1,454 million in 2016, and is estimated to reach $2,108 million by 2023, growing at a CAGR of 5.0% during the analysis period of 2017–2023.

Rise in prevalence of chronic illnesses throughout the world, growth in demand for effective diagnostic systems, and increased coverage for PET-CT scanning under Medicare drive the market. Surge in use of PET-CT for cancer diagnosis is expected to further boost the market growth. Moreover, development of newer products and increase in investments in R&D by companies contribute toward the revenue growth of the market. However, limited shelf life and inadequate availability of radiopharmaceuticals are expected to hinder the market growth.

The global PET-CT scanning market is segmented based on type, service provider, type, slice count, isotopes, application and region. On basis of type, the market is bifurcated into stationary scanners and portable scanners/mobile scanners. Based on service provider, the market is classified into hospitals, diagnostic centers, and research institutes. By slice count, the market is categorized into low slice scanner (<64 slices), medium slice scanner (64 slices), and high slice scanner (>64 slices). Based on isotopes, the market is segmented into Flurodeoxyglucose (FDG), 62Cu ATSM, 18 F Sodium Fluoride, FMISO, Gallium, Thallium and Others. Based on application, the market is categorized into oncology, neurology, cardiology, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global PET-CT scanner device market, with current trends and future estimations to elucidate investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis to help stakeholders capitalize on prevailing market opportunities from 2017 to 2023 in terms of value.
Extensive analysis of different segments helps understand various products of the market.
Key players are profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

KEY PLAYERS PROFILED

Toshiba Corporation
General Electric Co.
Hitachi, Ltd.
Koninklijke Philips N.V.
Shimadzu Corporation
Siemens AG
PerkinElmer, Inc.
Positron Corporation
Yangzhou Kindsway Biotech Co. Ltd
Mediso Ltd

KEY MARKET SEGMENTS

By Type

Stationary Scanners
Portable Scanners/ Mobile Scanners

By Service Provider

Hospitals
Diagnostic Centers
Research Institutes

By Slice Count

Low Slice Scanner (<64 Slices)
Medium Slice Scanner (64 Slices)
High Slice Scanner (>64 Slices)

By Isotopes / Detector Types

Flurodeoxyglucose (FDG)
62Cu ATSM
18 F Sodium Fluoride
FMISO
Gallium
Thallium
Others


By Application

Oncology
Neurology
Cardiology
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA

The other players operating in the PET-CT scanner device market include (companies not profiled in the report):

NeuroLogica Corporation
NaturSoft Medical Systems Co., Ltd.
Shenzhen Anke High-Tech
Trivitron Technologies
Shenzhen Anke High-tech Co.